 |
Immune globulin intravenous (human) |
|---|---|
| Trade Name | Iveegam, Immuno |
| Orphan Indication | Juvenile rheumatoid arthritis |
| USA Market Approval | USA |
| USA Designation Date | 1992-12-16 00:00:00 |
| Sponsor | Immuno Clinical Research Corp.;750 Lexington Avenue;New York, New York, 10022 |
